You are here

Articles

Media-

published: 10 December 2009

MP's - template letter regarding NICE ACD

published: 10 December 2009

NICE- information for you to use- plus direct link to no.10 petition

published: 1 December 2009

Find Your MP

published: 24 November 2009

NICE ACD- nilotinib/dasatinib - links

published: 20 November 2009

Dr.Brian Druker Interview NYTimes

published: 4 November 2009

7 year data from IRIS trial- ASH 2008

published: 4 November 2009

Peninsula Health Technology Commissioning Group Commissioning decision: dasatinib and nilotinib in the management of CML

published: 22 October 2009

e-cancer - Discovery offers hope for new cancer treatments

published: 19 October 2009

October is CML Awareness Month - The Max Foundation

published: 15 October 2009

EMEA: Pandemic influenza (H1N1) website

published: 2 October 2009

2009 CML Patient and Carer Education Day, 14th November, Nottingham, UK

published: 14 August 2009

ASCO 2009 -Omacetaxine active w/minimal toxicity in T315i positive CML patients who failed imatinib

published: 11 August 2009

Cutting-edge drugs to be fast-tracked, bypassing NICE

published: 17 July 2009

A New Campaign: European Action Against Rare Cancers has been launched: please sign petition

published: 29 June 2009

HealthDay News -- Low levels of vitamin D may contribute to cancer development, U.S. researchers have found.

published: 18 June 2009

h1n1Flu -pandemic- Interim Guidance on Pneumococcal polysaccharideVaccines

published: 12 June 2009

IFN-? wakes up sleeping hematopoietic stem cells- Emmanuelle Passegué & Patricia Ernst Nature Medicine

published: 9 June 2009

Vitamin D - inadequate levels may be implicated in development of early cancer cell

published: 2 June 2009

ASCO 2009

published: 1 June 2009